Analytical, Diagnostic and Therapeutic Techniques and Equipment – Anesthesia and Analgesia

At Maxima Medisch Centrum, researchers are advancing pain management strategies by testing new regional anesthesia techniques and multimodal analgesic protocols to improve patient comfort during procedures.

  • Development of ultrasound‑guided nerve blocks
  • Evaluation of multimodal analgesia regimens
  • Assessment of patient‑reported pain outcomes
  • Safety studies of novel anesthetic agents
  • Implementation of opioid‑sparing approaches

With 28 active trials and 41 investigators, the program emphasizes reducing opioid reliance while maintaining effective peri‑operative care.

Analytical, Diagnostic and Therapeutic Techniques and Equipment – Therapeutics

The department focuses on innovative therapeutic devices and drug‑delivery systems to enhance treatment efficacy for chronic cardiac and metabolic conditions.

  • Development of implantable cardiac monitoring systems
  • Evaluation of targeted drug‑delivery platforms
  • Studies on wearable health technology
  • Optimization of infusion pump technologies
  • Validation of tele‑monitoring solutions for heart failure

Collaborative engineering partnerships support rapid translation of prototypes into clinical practice.

Analytical, Diagnostic and Therapeutic Techniques and Equipment – Surgical Procedures, Operative

Surgeons are investigating minimally invasive surgery and enhanced recovery pathways to shorten hospital stays and improve outcomes for abdominal and cardiac operations.

  • Laparoscopic approaches for colorectal disease
  • Robotic assistance in cardiac procedures
  • Peri‑operative antibiotic lavage studies after appendectomy
  • Evaluation of enhanced recovery after surgery (ERAS) protocols
  • Comparative trials of operative versus non‑operative management of appendicitis

The surgical team works closely with anesthesia and intensive care to streamline patient pathways.

Diseases – Cardiovascular Diseases

Cardiovascular research targets a spectrum from atherosclerosis to heart failure, testing new drugs and lifestyle interventions to lower major adverse cardiac events.

  • Trials on lipid‑lowering therapies for elevated Lp(a)
  • Evaluation of novel anti‑arrhythmic agents for atrial fibrillation
  • Studies on heart failure with preserved ejection fraction (HFpEF)
  • Investigation of anti‑inflammatory treatments for atherosclerotic disease
  • Assessment of cardio‑protective outcomes after surgical interventions

The cardiology unit leverages a large patient cohort to generate robust data on risk reduction.

Diseases – Congenital, Hereditary, and Neonatal Diseases and Abnormalities

The center conducts research on early‑life conditions, aiming to improve neonatal outcomes and prevent pregnancy‑related complications.

  • Evaluation of metformin for preterm preeclampsia
  • Allopurinol combined with therapeutic hypothermia for hypoxic‑ischemic encephalopathy
  • Research on hormonal influences in congenital heart defects
  • Assessment of maternal‑fetal monitoring technologies
  • Trials on early interventions for hereditary metabolic disorders

Multidisciplinary teams of obstetrics, neonatology, and genetics provide comprehensive care for mother‑infant dyads.

Diseases – Digestive System Diseases

Investigations address colorectal cancer and liver metastases, refining chemotherapy regimens and surgical timing to improve disease control.

  • Induction chemotherapy for locally advanced rectal cancer
  • Hepatic arterial infusion pump studies for unresectable liver metastases
  • Dose‑reduced chemotherapy in older colorectal cancer patients
  • Antibiotic lavage after appendectomy to prevent intra‑abdominal abscess
  • Metabolic modulation trials for functional gastrointestinal disorders

Gastroenterology and surgery collaborate to align systemic and local therapies for optimal outcomes.

Diseases – Female Urogenital Diseases and Pregnancy Complications

Research focuses on uterine fibroids, contraceptive innovations, and pregnancy‑related hypertension to enhance safety and quality of life.

  • Non‑surgical management of fibroids with ulipristal
  • Nonavalent HPV vaccine efficacy for vulvar HSIL
  • Contraception trials using weekly mifepristone
  • Metformin for prolonging gestation in preterm preeclampsia
  • Assessment of hormonal therapy impacts on reproductive health

Patient‑centered outcomes such as symptom severity and fertility preservation guide study designs.

Diseases – Hormonal diseases

Hormonal research includes studies on polycystic ovary syndrome, late‑onset hypogonadism, and metabolic endocrine disorders, testing hormonal modulation and lifestyle strategies.

  • Testosterone replacement outcomes after prostatectomy
  • Ovulation induction with letrozole versus gonadotropins
  • Treatment efficacy for late‑onset hypogonadism
  • Hormonal regulation studies in obesity
  • Adherence to endocrine therapy in breast cancer

Endocrinology collaborates with reproductive specialists to tailor individualized interventions.

Diseases – Neoplasms

Oncology trials span breast, lung, melanoma, and multiple myeloma, evaluating novel immunotherapy combinations and targeted agents to improve survival rates.

  • Combination immunotherapy for metastatic non‑small cell lung cancer
  • Palbociclib added to endocrine therapy in early breast cancer
  • Novel agents for relapsed multiple myeloma
  • Adjuvant therapy trials for stage III melanoma
  • Comparative studies of chemotherapy versus immunotherapy in squamous NSCLC

The cancer center integrates translational research to match molecular profiles with therapeutic options.

Diseases – Nutritional and Metabolic Diseases

Metabolic studies target obesity and elevated lipoprotein(a), assessing novel agents that modify lipid pathways and reduce cardiovascular risk.

  • Lepodisiran for Lp(a) reduction
  • Orforglipron impact on cardiovascular outcomes
  • Muvalaplin evaluation for major cardiovascular events
  • Semaglutide use in atrial fibrillation patients with obesity
  • Weight‑loss intervention trials and metabolic effects

Nutritionists and cardiologists work together to address the intersection of metabolism and heart health.

Diseases – Virus Diseases

Viral disease research includes the evaluation of HPV vaccination strategies and management of virus‑related cancers to reduce infection‑driven malignancies.

  • Nonavalent HPV vaccine for vulvar HSIL prevention
  • Antiviral strategies in virus‑associated cancers
  • Immune response assessment to viral antigens in oncology
  • Vaccine uptake studies in high‑risk populations
  • Management of viral infections in immunocompromised patients

Public‑health outreach programs support education on vaccination benefits.

Health Care – Environment and Public Health

The site examines how environmental exposures influence disease prevalence, focusing on interventions that improve population public health policies.

  • Impact of air pollution on atherosclerotic disease incidence
  • Community‑based lifestyle intervention studies
  • Health‑care resource utilization analyses in chronic disease
  • Environmental exposure effects on pregnancy outcomes
  • Cost‑effectiveness of preventive public‑health programs

Partnerships with municipal health agencies enable large‑scale population research.

Health Care – Health Care Economics and Organizations

Economic analyses assess the cost‑effectiveness of innovative therapies and organizational models to optimize patient pathways and resource allocation.

  • Budget impact of novel heart‑failure medications
  • Economic evaluation of minimally invasive surgical techniques
  • Health‑technology assessment of diagnostic equipment
  • Comparative analysis of inpatient versus outpatient management
  • Modeling long‑term outcomes for oncology treatments

Health economists collaborate with clinicians to inform reimbursement and policy decisions.

Phenomena and Processes – Reproductive and Urinary Physiological Phenomena

Studies explore the physiology of reproductive and urinary systems, aiming to improve diagnostics for conditions such as urolithiasis and PCOS.

  • Biomarker discovery for urinary stone formation
  • Hormonal profiling in polycystic ovary syndrome
  • Evaluation of renal colic pain‑management techniques
  • Investigation of urinary tract infection recurrence patterns
  • Research on reproductive hormone cycles and fertility outcomes

Collaboration with laboratory medicine enhances translational insights into reproductive and urinary health.